Burkhardt Fugmann

Title: Burkhardt Fugmann: Innovator in Medicinal Chemistry

Introduction

Burkhardt Fugmann is a notable inventor based in Ratingen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the pharmaceutical industry.

Latest Patents

Fugmann holds a patent for "Heterocyclylcarbonyl substituted benzofuranyl-ureas." This invention involves the preparation of heterocyclylcarbonyl substituted 3-amino-benzofuranes by reacting them with appropriate isocyanates or isothiocyanates. The process allows for the transformation of unsubstituted ureas into substituted ureas through conventional substitution methods. These heterocyclylcarbonyl substituted benzofuranyl-ureas are particularly useful as active ingredients in medicaments aimed at treating acute and chronic inflammatory processes. He has 1 patent to his name.

Career Highlights

Fugmann is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on developing innovative solutions that address pressing medical needs. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Fugmann has collaborated with esteemed colleagues, including Graham Sturton and Rolf Henning. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Burkhardt Fugmann's work exemplifies the impact of innovation in the field of medicinal chemistry. His patent for heterocyclylcarbonyl substituted benzofuranyl-ureas showcases his commitment to developing effective treatments for inflammatory conditions. His contributions continue to influence the pharmaceutical landscape positively.